ABSCIENCES (EPA:AB) | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Companies
ABSCIENCES

PRESS RELEASE

published on 05/17/2024 at 17:58, 2 years 3 months ago

AB Science communique un rectificatif sur les comptes consolidés au 31 décembre 2023
AB Science corrige une erreur comptable affectant les comptes consolidés 2023. La perte opérationnelle diminue de 15,7% par rapport à 2022. Analyse détaillée des charges et produits financiers. Pas d'impact sur les comptes sociaux

Comptes Consolidés Résultat Financier Erreur Comptable AB Science Baisse Charges Opérationnelles
BRIEF

published on 05/15/2024 at 20:21, 2 years 3 months ago

Réduction des pertes opérationnelles et avancées importantes dans le développement clinique pour AB Science en 2023

Résultats Financiers Développement Clinique AB Science Masitinib Sclérose Latérale Amyotrophique
BRIEF

published on 05/15/2024 at 20:21, 2 years 3 months ago

Reduction in operational losses and significant advances in clinical development for AB Science in 2023

Financial Results Clinical Development AB Science Masitinib Amyotrophic Lateral Sclerosis
PRESS RELEASE

published on 05/15/2024 at 20:16, 2 years 3 months ago

AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités
AB Science annonce ses résultats financiers annuels 2023, événements clés de développement clinique et renforcement de propriété intellectuelle

Résultats Financiers Développement Clinique Propriété Intellectuelle AB Science Masitinib
PRESS RELEASE

published on 05/15/2024 at 20:16, 2 years 3 months ago

AB Science reports its revenues for the year 2023 and provides an update on its activities
AB Science presents financial information for the year 2023, including clinical development updates and intellectual property strengthening. Consolidated operating loss decreased by 15.7% compared to 2022

Financial Information Clinical Development Intellectual Property Operating Loss AB Science

Accesswire

Published on 09/12/2026 at 02:35, 11 hours 1 minute ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 36 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 31 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 11 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 36 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 6 hours 5 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 21 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 25 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 51 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 20 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE